How Can the High-Performing Specialty Pharmacy Association Benefit Pharma Manufacturers?



 
Truitt: These pharmacies produce top level outcomes, great results in persistence and compliance, and they also invest heavily in information technology to facilitate care and to coordinate reporting. So the concept is to work together to leverage purchasing, reporting, access to limited distribution drugs, and programs around that, and to provide payers with access to a large, high quality, specialty pharmacy network with broad access to drugs.

Most Popular

Related Articles

Specialty therapies for autoimmune diseases and cancer topped the list of biggest-selling drugs for 2018.
A data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.
The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$